13F-HR filed by ADAR1 Capital Management, LLC
ADAR1 Capital Management, LLC filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 277 holding rows worth $2,185,183,006.
- Accession
- 0001940272-26-000015
- Filer
- CIK 1940272
- Filed
- 2026-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 277 entries on the cover page, a total value of $2,185,183,006 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,185,183,006 with VALUE read as dollars as filed, 13F file number 028-23931. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 1,804,703 | $240,494,722 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 960,863 | $117,782,587 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 3,157,008 | $111,726,513 | dollars as filed | |
| SPY | 78462F103 | SHS | 129,087 | $96,398,299 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 2,330,716 | $89,802,487 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 3,369,034 | $64,011,646 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 1,288,053 | $47,799,647 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 1,222,080 | $45,730,234 | dollars as filed | |
| EA SERIES TRUST | 02072L565 | ALPHA ARCH 1-3 | 337,125 | $39,473,966 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 457,907 | $39,009,097 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 940,747 | $31,505,617 | dollars as filed | |
| ANTERIS TECHNOLOGIES GLOBAL | 03675P102 | COMMON STOCK | 3,145,096 | $30,979,196 | dollars as filed | |
| EDITAS MEDICINE INC | 28106W103 | COM | 8,889,000 | $28,800,360 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 1,029,080 | $26,467,938 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 283,982 | $25,211,922 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 2,456,677 | $25,033,539 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 74,253 | $24,859,162 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 228,520 | $24,364,802 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 619,542 | $23,053,158 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 574,038 | $22,393,222 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 3,040,466 | $20,705,573 | dollars as filed | |
| MONOPAR THERAPEUTICS INC | 61023L207 | COMMON STOCK | 217,595 | $20,147,121 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 7,417,479 | $19,953,019 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 387,718 | $19,676,689 | dollars as filed | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 1,344,510 | $19,602,956 | dollars as filed | |
| iShares Russell 2000 ETF | 464287655 | SHS | 62,500 | $18,778,125 | dollars as filed | put |
| SPY | 78462F103 | SHS | 25,000 | $18,669,250 | dollars as filed | put |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 244,184 | $17,046,485 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 374,617 | $16,711,664 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 87,509 | $16,388,686 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 185,619 | $15,927,966 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 1,554,535 | $15,218,898 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 136,158 | $15,117,623 | dollars as filed | |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | COMMON STOCK | 7,387,205 | $14,996,026 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 324,672 | $14,954,392 | dollars as filed | |
| RALLYBIO CORP | 75120L209 | COM | 926,352 | $14,821,632 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 22,208 | $13,847,576 | dollars as filed | |
| INVENTIVA SA | 46124U107 | ADS | 3,606,656 | $13,633,160 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367201 | COMMON STOCK | 404,014 | $13,413,265 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 166,286 | $13,184,817 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 176,689 | $13,159,797 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 730,649 | $13,129,763 | dollars as filed | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 3,365,118 | $12,619,193 | dollars as filed | |
| VOR BIOPHARMA INC | 929033207 | COMMON STOCK | 680,626 | $12,530,325 | dollars as filed | |
| SPDR Bloomberg 1-3 Month T-Bill ETF | 78468R663 | SHS | 135,585 | $12,425,009 | dollars as filed | |
| EQUILLIUM INC | 29446K106 | COM | 3,758,569 | $12,027,421 | dollars as filed | |
| Adlai Nortye | 00704R109 | SPONSORED ADS | 1,017,805 | $11,704,758 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 822,649 | $10,727,343 | dollars as filed | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 67,400 | $10,666,050 | dollars as filed | put |
| HELIX ACQUISITION CORP III | G4444S107 | USD CL A ORD SHS | 1,000,000 | $10,600,000 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 1,759,295 | $10,379,841 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 2,238,684 | $10,208,399 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 339,276 | $10,123,996 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 166,550 | $10,052,958 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 277,848 | $9,413,490 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 252,395 | $9,288,136 | dollars as filed | |
| FAETH THERAPEUTICS INC | 81728A207 | COM NEW | 361,010 | $9,025,250 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 494,378 | $8,879,029 | dollars as filed | |
| DBV TECHNOLOGIES S A | 23306J309 | SPONSORED ADS | 528,295 | $8,664,038 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 1,403,409 | $8,644,999 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 146,034 | $8,488,956 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 118,664 | $8,431,077 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 298,886 | $8,063,944 | dollars as filed | |
| ASCENDIS PHARMA A/S | K08588103 | ORD SHS *A* | 28,604 | $7,629,259 | dollars as filed | |
| AMANAT ACQUISITION CORP | G0375M101 | CL A ORD | 750,000 | $7,620,000 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 313,236 | $7,599,105 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 501,687 | $7,465,103 | dollars as filed | |
| PRIME MEDICINE INC | 74168J101 | COM | 1,997,552 | $7,370,967 | dollars as filed | |
| PERCEPTIVE CAPITAL SOLUTIONS | G70077105 | CL A ORD SHS | 674,695 | $7,340,682 | dollars as filed | |
| OPUS GENETICS INC | 67577R102 | COMMON STOCK | 1,783,781 | $7,331,340 | dollars as filed | |
| LEXEO THERAPEUTICS INC | 52886X107 | COMMON STOCK | 1,565,950 | $7,289,497 | dollars as filed | |
| DAMORA THERAPEUTICS INC | 36322Q206 | COMMON STOCK | 280,000 | $7,282,800 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 655,784 | $7,259,529 | dollars as filed | |
| LeonaBio Inc | 04746L203 | COM | 777,100 | $7,141,549 | dollars as filed | |
| KORRO BIO INC | 500946108 | COMMON STOCK | 540,054 | $7,117,912 | dollars as filed | |
| Research Alliance Corp Iii Ord Shs Cl A | G75226103 | Common Stock | 650,000 | $6,955,000 | dollars as filed | |
| Inflarx Nv | N44821101 | COM | 3,000,000 | $6,720,000 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 358,333 | $6,704,410 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 420,881 | $6,464,732 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 5,509,724 | $6,281,085 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 1,341,394 | $6,143,585 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 16,420 | $6,102,821 | dollars as filed | |
| Arbutus Biopharma Corp | 03879J100 | Common Shares, without par value | 1,268,147 | $6,087,106 | dollars as filed | |
| Pfizer Inc. | 717081103 | COM | 252,400 | $6,077,792 | dollars as filed | |
| BRIGHTHOUSE FINL INC | 10922N103 | COM | 95,523 | $6,046,606 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 44,400 | $5,916,744 | dollars as filed | call |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 143,199 | $5,818,175 | dollars as filed | |
| ALECTOR INC | 014442107 | COMMON STOCK | 2,883,583 | $5,796,002 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 1,565,029 | $5,728,006 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 69,800 | $5,689,398 | dollars as filed | |
| ACUMEN PHARMACEUTICALS INC | 00509G209 | CMN | 2,111,334 | $5,637,262 | dollars as filed | |
| OAKTREE ACQUISITION CORP III | G6717R120 | UNIT 10/04/2029 | 516,482 | $5,598,665 | dollars as filed | |
| GLOBUS MED INC CL A | 379577208 | Stock | 70,100 | $5,538,601 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 216,752 | $5,245,398 | dollars as filed | |
| DISCIPLINED GROWTH | G2775W127 | UNIT 99/99/9999 | 500,000 | $5,020,000 | dollars as filed | |
| Bhav Acquisition Corp Unit 03/18/2031 | G1R59W127 | Unit | 495,000 | $5,004,450 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806XAJ1 | NOTE 1.750% 3/0 | 30,000 | $4,999,140 | dollars as filed | principal |
| Bridgebio Pharma Inc Note 2.250 percent 2/0 | 10806XAD4 | Convertible | 45,000 | $4,941,630 | dollars as filed | principal |
| Danaher Corporation | 235851102 | COM | 25,932 | $4,939,527 | dollars as filed | |
| BOUNDLESS BIO INC | 10170A100 | COM | 1,968,216 | $4,920,540 | dollars as filed | |
| AVALYN PHARMA INC | 05348Y105 | COMMON STOCK | 146,447 | $4,821,035 | dollars as filed | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 600,999 | $4,814,002 | dollars as filed | |
| ATAIBECKLEY INC | 04650F101 | COM SHS | 913,242 | $4,812,785 | dollars as filed | |
| PRELUDE THERAPEUTICS INC | 74065P101 | CMN | 900,900 | $4,801,797 | dollars as filed | |
| JATT II ACQUISITION CORP | G50765109 | ORD SHS | 417,724 | $4,745,345 | dollars as filed | |
| REIN THERAPEUTICS INC | 00887A204 | COM NEW | 4,500,000 | $4,680,000 | dollars as filed | |
| PEPGEN INC COM | 713317105 | Stock | 2,591,085 | $4,663,953 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 278,961 | $4,572,171 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 1,210,117 | $4,126,499 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 31,000 | $4,114,630 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 118,623 | $4,020,133 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 421,787 | $3,956,362 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 17,900 | $3,867,474 | dollars as filed | |
| XENCOR INC | 98401F105 | COMMON STOCK | 232,560 | $3,744,216 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 338,373 | $3,715,336 | dollars as filed | |
| SPRUCE BIOSCIENCES INC | 85209E208 | COM NEW | 67,717 | $3,656,718 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 105,528 | $3,649,158 | dollars as filed | |
| ENGENE THERAPEUTICS INC | 29286X101 | COM | 2,104,986 | $3,641,626 | dollars as filed | |
| PALISADE BIO INC | 696389402 | COMMON STOCK | 1,726,662 | $3,608,724 | dollars as filed | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 940,512 | $3,592,756 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806XAB8 | NOTE 2.500% 3/1 | 20,000 | $3,461,880 | dollars as filed | principal |
| SAGIMET BIOSCIENCES INC A | 786700104 | COMMON STOCK | 437,500 | $3,381,875 | dollars as filed | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 11,701 | $3,334,434 | dollars as filed | |
| INVIVYD INC | 00534A102 | COMMON STOCK | 3,807,427 | $3,321,599 | dollars as filed | |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 220,462 | $3,207,722 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 652,750 | $3,165,838 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 451,918 | $3,127,273 | dollars as filed | |
| DELCATH SYSTEMS INC | 24661P807 | COMMON STOCK | 224,385 | $2,825,007 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 49,000 | $2,803,780 | dollars as filed | |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 191,869 | $2,795,531 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 246,818 | $2,640,953 | dollars as filed | |
| ELEDON PHARMACEUTICALS INC | 28617k101 | COM | 647,812 | $2,552,379 | dollars as filed | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 57,100 | $2,435,886 | dollars as filed | |
| AMERICAN EXCEPTIONALISM ACQU | G0273J101 | ORD CL A | 205,408 | $2,427,923 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 76,761 | $2,399,549 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 6,030 | $2,398,010 | dollars as filed | |
| INOVIO PHARMACEUTICALS I | 45773H409 | COMMON STOCK | 2,143,910 | $2,358,301 | dollars as filed | |
| OMNIAB INC | 68218J103 | COM | 947,412 | $2,330,634 | dollars as filed | |
| CAPRICOR THERAPEUTICS INC | 14070B309 | COMMON STOCK | 90,593 | $2,181,479 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 30,300 | $2,127,060 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 20,840 | $1,983,343 | dollars as filed | |
| VYNE THERAPEUTICS INC | 92941V308 | COM | 2,950,000 | $1,919,565 | dollars as filed | |
| MCKESSON CORP COM | 58155Q103 | Stock | 2,500 | $1,889,000 | dollars as filed | |
| LEXICON PHARMACEUTICALS INC | 528872302 | COMMON STOCK | 750,000 | $1,800,000 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 117,101 | $1,749,489 | dollars as filed | |
| CUE BIOPHARMA INC | 22978P205 | COM | 55,193 | $1,741,891 | dollars as filed | |
| SATELLOS BIOSCIENCE INC | 80401L803 | COM | 222,555 | $1,731,478 | dollars as filed | |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 26,913 | $1,721,086 | dollars as filed | |
| CONNECT BIOPHARMA HLDGS LTD | G23549101 | SHS | 700,000 | $1,666,000 | dollars as filed | |
| Cohen Circle Acquisit Corp I Unit 07/01/2030 | G2254C105 | Unit | 150,000 | $1,576,500 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 435,500 | $1,489,410 | dollars as filed | |
| FIRST TRACKS BIOTHERAPEUTICS | 337185102 | ORD SHS *A* | 71,910 | $1,446,829 | dollars as filed | |
| EVOMMUNE INC | 30054Y107 | COMMON STOCK | 104,035 | $1,382,625 | dollars as filed | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 291,957 | $1,363,439 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 133,000 | $1,330,000 | dollars as filed | |
| SUPERNUS PHARMACEUTICALS | 868459108 | COM | 27,842 | $1,294,931 | dollars as filed | |
| NOVO-NORDISK A S ADR | 670100205 | ADR | 27,000 | $1,294,380 | dollars as filed | |
| AVANTOR INC COM | 05352A100 | Stock | 130,000 | $1,287,000 | dollars as filed | |
| INMED PHARMACEUTICALS INC | 457637700 | COM NEW | 800,000 | $1,240,000 | dollars as filed | |
| PROMIS NEUROSCIENCES INC | 74346M505 | COM SHS | 92,850 | $1,221,906 | dollars as filed | |
| Arrowhead Pharmaceuticals In Note 1/1 | 04280AAC4 | Convertible | 10,000 | $1,190,560 | dollars as filed | principal |
| ARTIVA BIOTHERAPEUTICS INC | 04317A107 | COM | 118,624 | $1,150,653 | dollars as filed | |
| TENAYA THERAPEUTICS INC | 87990A106 | COM | 1,555,500 | $1,149,670 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 533,660 | $1,104,676 | dollars as filed | |
| ALEXANDRIA REAL ESTATE EQ INC COM | 015271109 | REIT | 19,500 | $1,030,575 | dollars as filed | |
| CARTESIAN THERAPEUTICS INC | 816212302 | COMMON STOCK | 98,877 | $1,030,298 | dollars as filed | |
| Cyclerion Therapeutics Inc | 23255M204 | COM | 298,757 | $1,012,786 | dollars as filed | |
| ELECTRONIC ARTS INC COM | 285512109 | Stock | 4,936 | $1,012,077 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422GAB3 | NOTE 0.500% 5/1 | 10,000 | $1,000,000 | dollars as filed | principal |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 10,600 | $986,330 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 38,955 | $985,562 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 42,821 | $951,054 | dollars as filed | |
| MAPLIGHT THERAPEUTICS INC | 56565P103 | COMMON STOCK | 26,497 | $949,652 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 17,500 | $939,225 | dollars as filed | |
| KEEN VISION ACQUISITION CORP | G52443119 | SHS | 75,000 | $930,000 | dollars as filed | call |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 160,000 | $929,600 | dollars as filed | |
| AURA BIOSCIENCES INC | 05153U107 | COMMON STOCK | 130,152 | $924,079 | dollars as filed | |
| CHURCHILL CAP CORP XI | G2131A108 | CL A ORD SHS | 50,000 | $872,500 | dollars as filed | |
| KAZIA THERAPEUTICS LTD | 48669G303 | SPONSORED ADS | 61,550 | $866,624 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 6,942 | $857,337 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 272,745 | $831,872 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 18,322 | $786,197 | dollars as filed | |
| Adagio Med Hldgs Inc Com | 00534B100 | Common Stock | 1,205,447 | $785,469 | dollars as filed | |
| ATRIUM THERAPEUTICS INC COM | 04965N104 | Stock | 57,688 | $775,904 | dollars as filed | |
| THERAPEUTICSMD INC | 88338N206 | COM NEW | 342,447 | $756,808 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 20,000 | $745,400 | dollars as filed | |
| SI BONE INC | 825704109 | COM | 45,000 | $734,400 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 40,100 | $720,196 | dollars as filed | put |
| ROYALTY PHARMA PLC | G7709Q104 | SHS CLASS A | 12,500 | $700,875 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 100,000 | $694,000 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 20,000 | $667,800 | dollars as filed | call |
| IBIO INC | 451033708 | CMN | 375,531 | $657,179 | dollars as filed | |
| FORWARD AIR CORP COM | 34986A104 | Stock | 48,241 | $651,736 | dollars as filed | |
| GERON CORP | 374163103 | COM | 505,817 | $647,446 | dollars as filed | |
| Stryker Corporation | 863667101 | COM | 2,000 | $629,680 | dollars as filed | |
| NOVO-NORDISK A S ADR | 670100205 | ADR | 13,000 | $623,220 | dollars as filed | call |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 146,090 | $607,734 | dollars as filed | |
| MACROGENICS INC | 556099109 | COM | 129,822 | $599,778 | dollars as filed | |
| Gilead Sciences,Inc. | 375558103 | COM | 4,648 | $587,228 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 2,147 | $582,803 | dollars as filed | |
| SEAPORT THERAPEUTICS INC | 81221K108 | COMMON STOCK | 26,000 | $564,720 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 60,000 | $562,800 | dollars as filed | call |
| ASSEMBLY BIOSCIENCES INC | 045396207 | COMMON STOCK | 20,447 | $561,884 | dollars as filed | |
| CYBIN INC | 23256X407 | COM NEW | 81,278 | $537,248 | dollars as filed | |
| BENITEC BIOPHARMA INC | 08205P209 | COMMON STOCK | 40,000 | $535,200 | dollars as filed | |
| POLYPID LTD | M8001Q126 | COM | 103,950 | $528,066 | dollars as filed | |
| PULMONX CORP | 745848101 | COM | 404,497 | $525,846 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 27,000 | $525,690 | dollars as filed | |
| Globa Terra Acquisition Cor Unit 99/99/9999 | G3933N108 | Unit | 50,000 | $519,500 | dollars as filed | |
| TRAWS PHARMA INC | 68232V884 | COM NEW | 597,729 | $504,065 | dollars as filed | |
| WISDOMTREE TR | 97717Y527 | FLOATNG RAT TREA | 10,000 | $503,500 | dollars as filed | |
| TECTONIC THERAPEUTIC INC | 878972108 | COMMON STOCK | 14,501 | $498,472 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 895 | $480,570 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 57,591 | $478,581 | dollars as filed | |
| ORTHOPEDIATRICS CORP | 68752L100 | COMMON STOCK | 25,000 | $478,250 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 12,200 | $472,140 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 42,900 | $465,465 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 3,900 | $456,573 | dollars as filed | |
| KIORA PHARMACEUTICALS INC | 49721T507 | COM | 167,941 | $441,685 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 40,000 | $438,800 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 750,969 | $415,962 | dollars as filed | |
| iShares 0-5 Year TIPS Bond ETF | 46429B747 | SHS | 4,000 | $408,640 | dollars as filed | |
| KALARIS THERAPEUTICS INC | 482929106 | COM | 100,000 | $407,000 | dollars as filed | |
| BICARA THERAPEUTICS INC | 055477103 | COM | 13,705 | $406,901 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 3,140 | $403,490 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 210,000 | $357,000 | dollars as filed | |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 3,000 | $356,850 | dollars as filed | |
| ACHIEVE LIFE SCIENCES INC | 004468500 | COMMON STOCK | 53,800 | $351,314 | dollars as filed | |
| ALIBABA GROUP HLDG LTD | 01609W102 | SPONSORED ADS | 3,578 | $343,416 | dollars as filed | |
| WW INTL INC | 98262P200 | COM NEW | 21,300 | $340,374 | dollars as filed | |
| CNS PHARMACEUTICALS INC | 18978H508 | COM | 70,000 | $334,600 | dollars as filed | |
| CRESCENT BIOPHARMA INC | G2545C104 | COMMON STOCK | 18,275 | $328,950 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 7,500 | $320,100 | dollars as filed | |
| ALTIMMUNE INC | 02155H200 | COM NEW | 102,823 | $312,582 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 75,800 | $289,556 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 58,808 | $284,631 | dollars as filed | |
| JOURNEY MED CORP | 48115J109 | COM | 39,517 | $279,780 | dollars as filed | |
| PROCAP ACQUISITION CORP | G7257A113 | UNIT 05/16/2030 | 26,940 | $279,368 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 201,008 | $269,351 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 122,132 | $267,469 | dollars as filed | |
| JD.COM INC SPON ADS CL A | 47215P106 | ADR | 10,000 | $254,800 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 48,679 | $253,131 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 3,698 | $249,615 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 7,800 | $245,310 | dollars as filed | |
| iShares U.S. Medical Devices ETF | 464288810 | SHS | 4,900 | $242,109 | dollars as filed | |
| RXSIGHT INC | 78349D107 | COM | 50,000 | $241,000 | dollars as filed | |
| COYA THERAPEUTICS INC | 22407B108 | CMN | 40,900 | $239,265 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 50,638 | $214,705 | dollars as filed | |
| CANTOR EQUITY PARTNERS VI IN | G1828R101 | CL A ORD SHS | 20,000 | $207,400 | dollars as filed | |
| SCYNEXIS INC | 811292309 | COM | 49,387 | $201,005 | dollars as filed | |
| PERSONALIS INC | 71535D106 | COMMON STOCK | 15,000 | $201,000 | dollars as filed | |
| Q C Technologies Inc | 62856X300 | COM | 50,000 | $195,000 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 50,000 | $155,500 | dollars as filed | |
| RECURSION PHARMACEUTICALS IN | 75629V104 | CL A | 41,000 | $150,470 | dollars as filed | |
| ORGANON & CO COMMON STOCK | 68622V106 | Stock | 10,000 | $135,400 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 100,000 | $134,000 | dollars as filed | |
| NEUPHORIA THERAPEUTICS INC | 64136E102 | COM | 30,000 | $131,100 | dollars as filed | |
| NEURONETICS INC | 64131A105 | COM | 100,000 | $130,000 | dollars as filed | |
| CHEMOMAB THERAPEUTICS LTD | 16385C203 | SPONSORED ADS | 80,000 | $129,600 | dollars as filed | |
| SOLIDION TECHNOLOGY INC | 834212201 | COM NEW | 13,500 | $125,415 | dollars as filed | call |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 35,000 | $122,500 | dollars as filed | |
| ENTRADA THERAPEUTICS INC COM | 29384C108 | Stock | 15,500 | $114,080 | dollars as filed | |
| VERU INC | 92536C202 | COM NEW | 35,000 | $109,550 | dollars as filed | |
| CANTOR EQUITY PARTNERS VII I | G1828W100 | CL A ORD SHS | 10,000 | $100,900 | dollars as filed | |
| CLENE INC | 185634201 | COM NEW | 15,000 | $92,325 | dollars as filed | |
| VISTAGEN THERAPEUTICS INC | 92840H400 | COM | 351,141 | $79,358 | dollars as filed | |
| LONGEVERON INC | 54303L203 | CL A NEW | 108,406 | $76,209 | dollars as filed | |
| BIOMEA FUSION INC | 09077A106 | CMN | 43,420 | $63,827 | dollars as filed | |
| LITE STRATEGY INC | 55279B301 | COM | 67,292 | $62,070 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871202 | COM NEW | 140,000 | $58,940 | dollars as filed | |
| ARDELYX INC | 039697107 | COM | 11,000 | $56,100 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 212,531 | $34,983 | dollars as filed | |
| ATYR PHARMA INC | 002120202 | COM NEW | 50,685 | $30,249 | dollars as filed | |
| A SPAC III ACQUISITION CORP | G0544A145 | RIGHT 01/02/2026 | 215,000 | $19,114 | dollars as filed | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 10,000 | $18,600 | dollars as filed | |
| BEST SPAC I ACQUISITION CORP | G1069P129 | RIGHT 05/27/2030 | 100,000 | $16,560 | dollars as filed | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 10,366 | $14,512 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001940272-26-000015 | this filing | 2026-08-14 | acceptance time not in the bulk data set |